Vettorazzi Marcello, Stocco Carmen, Chirico Antonino, Recanatini Silvia, Saccon Stefania, Mariotto Renata, Cinquetti Sandro, Moretto Tina, Sartori Paolo, Stomeo Anna, Ciatto Stefano
Registro Tumori Veneto, Padova, Italy.
Tumori. 2006 Jan-Feb;92(1):1-5. doi: 10.1177/030089160609200101.
Service mammography screening has been reported to have suboptimal performance compared to controlled trials. The aim of this study was to evaluate the sensitivity of the mammography screening program in four Local Health Units (ASL) and the possible causes of diagnostic error in cases further surfacing as interval cancers.
Interval cancers were identified by cross checking of screened women databases with hospital discharge records reporting breast cancer. Proportional interval cancer incidence (observed interval cancers/expected invasive cancers) was determined by matching the database of women screened during 1999-2002 to the hospital discharge records databases during 1999-2003. The ratio of observed interval cancer rate to underlying incidence was compared to international standards and with literature data. Screening mammograms reported as negative and followed by interval cancers were randomly mixed with true-negative controls, and the resulting set underwent blind review by an external radiologist who applied the conventional criteria recommended for the classification of the type of diagnostic error (occult, minimal signs, screening error).
Matching of screening archives with the hospital discharge records databases allowed for the identification of 154 invasive interval cancers compared to 480 expected. The proportional observed/expected interval cancer incidence in the first and second year of the interval was 21% and 46%, respectively (ASL 1 = 14% or 38%, ASL 2 = 19% or 48%, ASL 3 = 30% or 53%, ASL 4 = 25% or 49%). Radiological review included 38 further interval cancer cases, identified after the time limits defined for proportional interval cancer incidence assessment, and could not include 18 interval cancers, not retrieved from ASL 4 archives: overall, 174 interval cancers were reviewed, of which 135 were classified as occult (77.3%) (ASL 1 = 83.3%, ASL 2 = 71.1%, ASL 3 = 78.6%, ASL 4 = 75%), 12 (6.9%) as minimal signs (ASL 1 = 6.6%, ASL 2 = 11.5%, ASL 3 = 2.4%, ASL 4 = 5%), and 27 (15.5%) as screening error (ASL 1 = 8.3%, ASL 2 = 17.3%, ASL 3 = 19.0%, ASL 4 = 25%).
Observed proportional interval cancer incidence was lower than commonly reported for service screening programs and currently recommended (< 30% in the first, < 50% in the second year of the interval). The analysis of interval cancer causes showed a screening error rate below the maximum acceptable standard (< 20% of interval cancers should be classified as screening error) in three of four programs and in average figures. Substantial differences observed among single programs (one did not comply to recommended standards) suggest that space is available for the improvement of overall performance by optimizing program organization and by further training of radiologists. Overall, the analysis showed a good sensitivity of the screening program in the Veneto Region, although the performance was inferior to that of excellence centers, and further action to improve it is possible. Assessment and review of interval cancers is an early indicator of screening efficacy which has not yet been fully adopted in Italian screening programs. Although using hospital discharge records to identify interval cancers may be affected by limited errors, such a procedure is particularly convenient, as data from hospital discharge records are available much in advance compared to cancer registries and are the most reliable source of information for areas uncovered by a cancer registry. Hospital discharge records-based procedures for interval cancers assessment should be employed routinely in screening programs.
与对照试验相比,据报道服务性乳腺钼靶筛查的表现欠佳。本研究的目的是评估四个地方卫生单位(ASL)的乳腺钼靶筛查项目的敏感性,以及作为间期癌进一步出现的病例中诊断错误的可能原因。
通过将筛查女性数据库与报告乳腺癌的医院出院记录进行交叉核对来识别间期癌。通过将1999 - 2002年筛查女性的数据库与1999 - 2003年医院出院记录数据库进行匹配,确定成比例的间期癌发病率(观察到的间期癌/预期浸润性癌)。将观察到的间期癌发病率与潜在发病率的比值与国际标准以及文献数据进行比较。报告为阴性且随后发生间期癌的筛查乳腺钼靶片与真正的阴性对照随机混合,然后由一名外部放射科医生进行盲法审查,该医生应用推荐的常规标准对诊断错误类型(隐匿性、微小征象、筛查错误)进行分类。
将筛查档案与医院出院记录数据库进行匹配后,共识别出154例浸润性间期癌,而预期为480例。间期第一年和第二年观察到的/预期的成比例间期癌发病率分别为21%和46%(ASL 1 = 14%或38%,ASL 2 = 19%或48%,ASL 3 = 30%或53%,ASL 4 = 25%或49%)。放射学审查包括另外38例间期癌病例,这些病例是在为成比例间期癌发病率评估定义的时间限制之后确定的,并且未包括从ASL 4档案中未检索到的18例间期癌:总体而言,共审查了174例间期癌,其中135例被分类为隐匿性(77.3%)(ASL 1 = 83.3%,ASL 2 = 71.1%,ASL 3 = 78.6%,ASL 4 = 75%),12例(6.9%)为微小征象(ASL 1 = 6.6%,ASL 2 = 11.5%,ASL 3 = 2.4%,ASL 4 = 5%),27例(15.5%)为筛查错误(ASL 1 = 8.3%,ASL 2 = 17.3%,ASL 3 = 19.0%,ASL 4 = 25%)。
观察到的成比例间期癌发病率低于服务性筛查项目通常报告的以及目前推荐的水平(间期第一年<30%,第二年<50%)。间期癌原因分析显示,在四个项目中的三个以及平均数据中,筛查错误率低于最大可接受标准(<20%的间期癌应被分类为筛查错误)。单个项目之间观察到的显著差异(一个未符合推荐标准)表明,通过优化项目组织和进一步培训放射科医生,仍有提高整体表现的空间。总体而言,分析表明威尼托地区的筛查项目具有良好的敏感性,尽管其表现不如卓越中心,并且有可能采取进一步行动来改善。间期癌的评估和审查是筛查效果的早期指标,意大利筛查项目尚未充分采用这一指标。尽管使用医院出院记录来识别间期癌可能会受到有限误差的影响,但这样的程序特别方便,因为与癌症登记处相比,医院出院记录的数据可提前很久获得,并且是癌症登记处未覆盖地区最可靠的信息来源。基于医院出院记录的间期癌评估程序应在筛查项目中常规使用。